MedPath

Follow-up Study of Transcranial Direct Current Stimulation to Treat Major Depressive Disorder

Phase 2
Completed
Conditions
Major Depressive Disorder
Registration Number
NCT01149213
Lead Sponsor
University of Sao Paulo
Brief Summary

The investigators purpose is to follow remitted patients from their previous study using transcranial direct current stimulation (tDCS); as to verify whether this treatment prevents relapse.

Detailed Description

Our first ongoing study (Efficacy Study of Transcranial Direct Current Stimulation (tDCS) to Treat Major Depressive Disorder) addresses whether tDCS is an effective treatment for depression treatment. The purpose of the present study is to determine whether tDCS is also an effective strategy for sustaining remission.

We will enroll patients who presented remission using tDCS from our previous study and offer them to tDCS every other week for three months, than once a month for another three months. We will address whether tDCS prevents relapse by assessing depression scores once a month, using a time-to-event analysis.

The importance of the present study is to determine whether tDCS is able to sustain remission during long-term follow-up of depressed patients.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
42
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Relapse from depressionWeek 24

Same as above.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University of Sao Paulo

🇧🇷

Sao Paulo, SP, Brazil

University of Sao Paulo
🇧🇷Sao Paulo, SP, Brazil

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.